MedPath

Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

Phase 4
Conditions
Heart Failure
Registration Number
NCT00418119
Lead Sponsor
Rabin Medical Center
Brief Summary

Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Ischemic heart disease
  • Systolic lv dysfunction
  • Mild anemia
  • Normal renal function
  • Stable condition
Exclusion Criteria
  • Pregnancy
  • Unstable condition
  • Under 18 years old

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cardiology Department, Rabin Medical Center

🇮🇱

Petah Tikva, Israel

Cardiology Department, Rabin Medical Center
🇮🇱Petah Tikva, Israel
Tuvia Ben Gal, MD
Principal Investigator
Daniel Murninkas, MD
Sub Investigator
Ofer Shpilberg, Prof.
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.